Advertisement

How I'll buy into emerging markets

GlaxoSmithKline
GlaxoSmithKline

As a global investor and student of the markets, I think UK share investors have things pretty good. Based on the returns from the FTSE All Share Index since 2008, or even the last few months, you might think I'm mad for saying that, but allow me to explain.

The volatility in the market the last few years has certainly been a challenge, but the UK has well-regulated markets and high corporate governance standards. The Corporate Governance Code and its regular revisions are particularly noteworthy and a practice I would like to see adopted by a certain large economy on the other side of the Atlantic -- but that's a topic for another day.